Literature DB >> 33583157

Overview of COVID-19 and neurological complications.

Nasrin Hosseini1, Shabnam Nadjafi1, Behnaz Ashtary2.   

Abstract

The sudden and storming onset of coronavirus 2 infection (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) was associated by severe acute respiratory syndrome. Recently, corona virus disease 19 (COVID-19) has appeared as a pandemic throughout the world. The mutational nature of the virus, along with the different means of entering and spreading throughout the body has involved different organs. Thus, patients are faced with a wide range of symptoms and signs. Neurological symptoms, such as anosmia, agnosia, stroke, paralysis, cranial nerve deficits, encephalopathy, meningitis, delirium and seizures, are reported as common complications affecting the course of the disease and its treatment. In this review, special attention was paid to reports that addressed the acute or chronic neurological manifestations in COVID-19 patients who may present acute respiratory syndrome or not. Moreover, we discussed the central (CNS) and peripheral nervous system (PNS) complications in SARS-Cov2-infected patients, and also the pathophysiology of neurological abnormalities in COVID-19.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Entities:  

Keywords:  Alzheimer’s disease; Guillain Barre syndrome; cerebrovascular disease; corona virus 2; encephalopathy; multiple sclerosis

Mesh:

Substances:

Year:  2021        PMID: 33583157     DOI: 10.1515/revneuro-2020-0116

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  3 in total

Review 1.  What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection?

Authors:  Monika Gudowska-Sawczuk; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-03-27       Impact factor: 5.923

Review 2.  (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19.

Authors:  Amela Jusic; Konstantinos Stellos; Lino Ferreira; Andrew H Baker; Yvan Devaux
Journal:  J Mol Cell Cardiol Plus       Date:  2022-07-28

3.  COVID-19: a novel risk factor for perioperative neurocognitive disorders.

Authors:  Penghui Wei; Wenyuan Lyu; Tiantian Wan; Qiang Zheng; Wenxi Tang; Jianjun Li; Jian-Jun Yang
Journal:  Br J Anaesth       Date:  2021-06-19       Impact factor: 11.719

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.